Disease: sinusitis

Genetic sequencing of the airborne fungal spectrum and air quality at a public hospital in Mexico City

mycolabadmin

Researchers tested the air inside and outside a Mexico City hospital to identify harmful fungi that could make patients sick. Using two different sampling methods, they found 27 different fungal species, including dangerous ones like Aspergillus fumigatus that cause serious infections especially in people with weakened immune systems. The study shows that hospitals need better air monitoring systems to protect vulnerable patients from these airborne infections.

Read More »

Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)

mycolabadmin

This research examined dangerous mold infections (Mucormycosis) that became more common after COVID-19. Scientists identified the types of molds causing these infections in Iran by testing 116 patient samples and 65 soil samples from across the country. They tested these molds against 13 different antifungal medications to find which drugs work best. The results showed that amphotericin B and posaconazole were the most effective medications, and patient samples were more susceptible to these drugs than environmental soil samples.

Read More »

Clinical Challenges and Predictive Risk Factors for Outcomes in COVID-19–Associated Mucormycosis

mycolabadmin

During the COVID-19 pandemic, a dangerous fungal infection called mucormycosis has become a serious complication, especially for patients with uncontrolled diabetes or those taking certain medications. Researchers studied 180 patients with this condition and found that the infection can spread from the sinuses to the eyes and brain, leading to severe outcomes. The most important factors in surviving this infection are early detection, keeping blood sugar controlled, careful use of steroids, and aggressive treatment with antifungal medications and sometimes surgery.

Read More »

Epidemiology of mucormycosis in COVID-19 patients in northwest Iran: Rhizopus arrhizus as the predominant species

mycolabadmin

During the COVID-19 pandemic, some patients developed a severe fungal infection called mucormycosis alongside their coronavirus infection. This study found that 63 COVID-19 patients in Iran developed mucormycosis, which primarily affected the sinuses and brain. The researchers identified that a fungus called Rhizopus arrhizus caused most infections, and patients who received corticosteroids (used to treat severe COVID-19) had a higher risk, especially those who developed diabetes from the steroids.

Read More »

Strategies and materials for the prevention and treatment of biofilms

mycolabadmin

Biofilms are sticky communities of bacteria that form on medical devices and surfaces, making infections very difficult to treat with antibiotics. This review explains how biofilms develop in stages and describes different ways to stop them from forming or to destroy them once they exist. Solutions include special coatings on medical implants, natural plant extracts like essential oils, and engineered proteins called antimicrobial peptides that fight bacteria without creating antibiotic resistance.

Read More »
Scroll to Top